Acalabrutinib
Obinutuzumab
Update Venetoclax in CLL
Zanubrutinib
NCCN COVID-19 Resources Page
Leukemia & Lymphoma Society
ASH: COVID-19 Resources for Managing Blood Cancers
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL